Sanofi
SNY | NASDAQ
$44.34
+$1.21 (+2.81%)
At close: Oct 30, 2026, 4:00 PM ET
$44.65
+$0.31 (+0.70%)
Pre-market:
Nov 2, 2026, 5:37 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 12.89 | 21.22 | 20.99 | 14.20 | 17.73 | 8.10 |
PEG Ratio | 0.28 | 11.43 | -0.65 | 0.50 | -0.36 | 0.02 |
PS Ratio | 2.15 | 2.63 | 2.72 | 2.79 | 2.82 | 2.67 |
PB Ratio | 1.41 | 1.50 | 1.53 | 1.51 | 1.61 | 1.58 |
P/FCF Ratio | 9.92 | 19.80 | 13.11 | 13.60 | 13.02 | 18.68 |
P/OCF Ratio | 8.30 | 12.84 | 11.04 | 10.76 | 10.49 | 13.38 |
OCF/S Ratio | 25.97 | 20.51 | 24.65 | 25.95 | 26.86 | 19.93 |
Debt / Equity Ratio | 0.28 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 |
Quick Ratio | 0.73 | 1.14 | 0.87 | 1.05 | 1.03 | 1.32 |
Current Ratio | 1.09 | 1.46 | 1.27 | 1.42 | 1.44 | 1.75 |
Asset Turnover | 0.37 | 0.33 | 0.33 | 0.32 | 0.33 | 0.33 |
Interest Coverage | 15.33 | 11.65 | 13.57 | 26.41 | 21.53 | 32.76 |
Return on Equity | 10.95% | 7.17% | 7.29% | 11.19% | 9.06% | 19.48% |
Return on Assets | 6.16% | 4.19% | 4.27% | 6.61% | 5.18% | 10.75% |
Return on Invested Capital | 7.70% | 5.51% | 5.53% | 7.67% | 6.36% | 12.54% |
Dividend Yield | 5.35% | 4.04% | 3.93% | 3.68% | 3.63% | 3.95% |
Payout Ratio | 68.93% | 84.60% | 82.48% | 49.79% | 64.41% | 32.02% |
FCF Payout Ratio | 53.09% | 79.92% | 51.56% | 51.58% | 48.67% | 73.80% |
Gross Profit Margin | 72.07% | 70.18% | 69.66% | 70.71% | 68.72% | 67.46% |
Net Profit Margin | 16.72% | 12.55% | 12.98% | 20.64% | 15.89% | 32.90% |
Pretax Profit Margin | 12.89% | 15.26% | 14.69% | 24.63% | 20.01% | 37.83% |
Operating Profit Margin | 20.54% | 16.38% | 16.72% | 25.05% | 20.74% | 37.77% |
FCF Margin | 21.71% | 13.29% | 20.76% | 20.52% | 21.64% | 14.28% |
EBITDA Margin | 26.71% | 24.91% | 27.37% | 33.31% | 29.45% | 47.86% |
Add to Watchlist
Select watchlists to add or remove SNY